Cargando…
Quantum modelling and molecular docking evaluation of some selected quinoline derivatives as anti-tubercular agents
Mycobacterium tuberculosis has instigated a serious challenge toward the effective treatment of tuberculosis. The reoccurrence of the resistant strains of the disease to accessible drugs/medications has mandate for the development of more effective anti-tubercular agents with efficient activities. T...
Autores principales: | Adeniji, Shola Elijah, Adamu Shallangwa, Gideon, Ebuka Arthur, David, Abdullahi, Mustapha, Mahmoud, A.Y., Haruna, Abdurrashid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114754/ https://www.ncbi.nlm.nih.gov/pubmed/32258484 http://dx.doi.org/10.1016/j.heliyon.2020.e03639 |
Ejemplares similares
-
Homology modeling and molecular docking simulation of some novel imidazo[1,2-a]pyridine-3-carboxamide (IPA) series as inhibitors of Mycobacterium tuberculosis
por: Abdullahi, Mustapha, et al.
Publicado: (2021) -
Binding profile of protein–ligand inhibitor complex and structure based design of new potent compounds via computer-aided virtual screening
por: Shallangwa, Gideon Adamu, et al.
Publicado: (2021) -
In-silico design and ADMET predictions of some new imidazo[1,2-a]pyridine-3-carboxamides (IPAs) as anti-tubercular agents
por: Abdullahi, Mustapha, et al.
Publicado: (2021) -
A Derived QSAR Model for Predicting Some Compounds as Potent Antagonist against Mycobacterium tuberculosis: A Theoretical Approach
por: Adeniji, Shola Elijah, et al.
Publicado: (2019) -
QSAR Modeling and Molecular Docking Analysis of Some Active Compounds against Mycobacterium tuberculosis Receptor (Mtb CYP121)
por: Adeniji, Shola Elijah, et al.
Publicado: (2018)